1. Home
  2. NSP vs NKTR Comparison

NSP vs NKTR Comparison

Compare NSP & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

SELL

Current Price

$48.75

Market Cap

1.9B

ML Signal

SELL

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$39.60

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
NKTR
Founded
1986
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NSP
NKTR
Price
$48.75
$39.60
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$51.75
★ $133.36
AVG Volume (30 Days)
434.2K
★ 1.7M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 4.92%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.97
N/A
Revenue
★ $6,812,000,000.00
$307,711,000.00
Revenue This Year
$1.40
N/A
Revenue Next Year
$4.27
$30.00
P/E Ratio
$49.85
★ N/A
Revenue Growth
3.51
★ 86.00
52 Week Low
$18.57
$33.40
52 Week High
$55.90
$109.00

Technical Indicators

Market Signals
Indicator
NSP
NKTR
Relative Strength Index (RSI) 48.75 22.47
Support Level $47.12 $33.87
Resistance Level $55.04 $76.63
Average True Range (ATR) 1.93 3.40
MACD 0.16 -1.42
Stochastic Oscillator 60.42 5.14

Price Performance

Historical Comparison
NSP
NKTR

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: